DRUG
MANUFACTURER:
Bayer Pharmaceuticals Corporation
DRUG
NAME:
Trasylol, also known as aprotinin
DRUG
INFO:
Trasylol, or aprotinin, a product derived from bovine lung
tissue, is a clotting drug that was injected during heart surgery to
prevent bleeding.
RECALL
INFO:
Trasylol
has been pulled from the U.S. market due to safety concerns of the Federal
Drug Administration (FDA).
FDA Requests Marketing Suspension of Trasylol
FDA Web site — November 5, 2007
Questions and Answers on Aprotinin (marketed as Trasylol)
FDA Web site — Last updated May 20, 2008
Bayer Halts Sale of Drug Used in Heart Surgery:
Trasylol Linked to Deaths After Procedure
Washington Post — November 6, 2007
TRASYLOL
PULLED FROM MARKET: Recalled drug can cause death, kidney failure,
stroke, or heart attack
On November 5, 2007, the
makers (Bayer Pharmaceuticals) of Trasylol removed the drug from the U.S.
market because of safety concerns of the Federal Drug Administration (FDA).
On the market since 1993, the drug was used in thousands of open heart
surgery procedures, and is likely to have injured or killed an unknown
number of patients.
Topics on this page:
Trasylol, also known as “Aprotinin,” is a blood clotting drug that was frequently used in open heart surgeries to prevent excessive bleeding and to minimize the need for transfusions. Trasylol is made from the lung tissue of cattle and it works by blocking enzymes that thin the blood or dissolve blood clots.
Trasylol manufacturer Bayer Pharmaceuticals, pulled the drug from the market in 2007 after studies showed that patients exposed to Trasylol during surgery faced a 50% increased risk of death compared to patients receiving other clotting drugs.
Although there were other, safer and cheaper clotting drugs on the market, Bayer actively marketed this much more expensive and dangerous drug until it was finally forced to remove the drug from the market due to FDA recommendations.
Patients having open heart surgeries such as coronary artery bypass grafting (CABG) or heart valve repair or replacement were likely to have Trasylol exposure. Almost all exposure to Trasylol occurred when physicians administered it during the course of lengthy open heart surgery procedures, because of the potential for significant blood loss. Physicians used Trasylol to encourage blood clotting and prevent excessive bleeding.
Unfortunately, the same clotting mechanism that prevented bleeding also caused irreversible injury to the kidneys, or created clots that resulted in strokes or heart attacks.
One of the most common medical complications caused by Trasylol is kidney or renal failure. Within days or weeks of normally successful heart surgery, recovering patients would develop kidney failure. These patients were placed on renal dialysis, and many died when their kidneys and other organs shut down completely.
Because Trasylol causes the blood to “thicken” or clot more easily, some patients developed blood clots (thrombus) that traveled to the brain, causing severe injury or death.
These are known as “ischemic” strokes because a clot travels to the brain or forms in the brain, causing a blockage in the arteries feeding blood to the brain. Trasylol does not cause “hemorrhagic” strokes, which occur when a blood vessel ruptures and bleeds into the space between the brain and the skull.
The same Trasylol clotting mechanism that causes strokes, has also caused exposed patients to experience post-surgical heart attacks. A heart attack occurs when the blood supply to the heart muscle is severely reduced or blocked.
The interruption of the blood supply happens when one or more of the coronary arteries supplying blood to the heart are blocked. Studies published in 2006 by the New England Journal of Medicine and the journal Transfusion reported that patients who were exposed to Trasylol during surgery had a 55% increased risk of heart attack or heart failure.
If you or a loved one has been injured because of exposure to Trasylol (aprotinin injection) during surgery, especially if you have suffered kidney failure and have needed dialysis, you may be entitled to compensation for:
If a loved one has died because Trasylol was used in surgery, you may be entitled to wrongful death compensation or compensation to the estate.
KCR personal injury attorneys have handled thousands of cases involving defective and dangerous drugs such as Trasylol. In recent years, KCR has litigated and settled numerous nationwide cases involving dangerous drugs and medical devices and products such as:
We have the specific knowledge and expertise to help our injured clients obtain fair compensation in these complex cases. Some of the recent cases we've resolved include:
If you or a loved one has been injured because of exposure to Trasylol (aprotinin injection) during surgery, please fill out and submit the contact form on this page for a free case evaluation or call us toll-free at (888) 285-3333.
HOME | CONTACT US | LEGAL SPECIALTIES | OUR ATTORNEYS | NEWS & INFORMATION | LEGAL RESOURCES | SITE MAP
Copyright © 2008 Kershaw, Cutter & Ratinoff LLP. All Rights Reserved.
SERVING YOU
Class
action attorneys | Wage and hour claims | California
personal injury lawyers
Head and spinal cord injuries |
Medical malpractice attorneys
Disclaimer: The legal information presented on this site should not be construed
as formal legal advice or the formation of a lawyer or attorney-client relationship.
If you need legal assistance or would like to discuss your case with an attorney,
please fill out and submit the form on this page or contact us
toll-free
at 888-285-3333.
Any results reported on this site are dependent on
the facts of that particular case; results will differ from case
to case.